HEADER HYDROLASE/INHIBITOR 20-APR-23 8SKN TITLE CRYSTAL STRUCTURE OF COMPOUND 3-BOUND HUMAN DYNAMIN-1-LIKE PROTEIN TITLE 2 GTPASE-BSE FUSION COMPND MOL_ID: 1; COMPND 2 MOLECULE: DYNAMIN-1-LIKE PROTEIN GTPASE-BSE FUSION; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 54-382,725-752; COMPND 5 EC: 3.-.-.-; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: DNM1L, HCG_1810949; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, HYDROLASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR B.MA REVDAT 1 30-AUG-23 8SKN 0 JRNL AUTH T.FURUYA,J.LIN,A.AFANASEVA,L.MOLZ,B.LAGU,B.MA JRNL TITL DISCOVERY OF POTENT ALLOSTERIC DRP1 INHIBITORS BY DISRUPTING JRNL TITL 2 PROTEIN-PROTEIN INTERACTION WITH MID49. JRNL REF ACS MED.CHEM.LETT. V. 14 1095 2023 JRNL REFN ISSN 1948-5875 JRNL PMID 37583827 JRNL DOI 10.1021/ACSMEDCHEMLETT.3C00223 REMARK 2 REMARK 2 RESOLUTION. 2.41 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.41 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.66 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 26672 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.208 REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : 0.256 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1438 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.41 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.47 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1956 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.76 REMARK 3 BIN R VALUE (WORKING SET) : 0.2640 REMARK 3 BIN FREE R VALUE SET COUNT : 108 REMARK 3 BIN FREE R VALUE : 0.3140 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5255 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 71 REMARK 3 SOLVENT ATOMS : 158 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 43.26 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.98000 REMARK 3 B22 (A**2) : -0.73000 REMARK 3 B33 (A**2) : 1.42000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.45000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.543 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.284 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.214 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 9.431 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.939 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.896 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5382 ; 0.006 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 5471 ; 0.001 ; 0.015 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7254 ; 1.386 ; 1.652 REMARK 3 BOND ANGLES OTHERS (DEGREES): 12563 ; 1.168 ; 1.588 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 663 ; 6.601 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 275 ;28.636 ;22.036 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1016 ;14.837 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 45 ;17.528 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 731 ; 0.064 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5922 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1145 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2676 ; 3.090 ; 4.387 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2675 ; 3.090 ; 4.387 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3331 ; 4.978 ; 6.551 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 3332 ; 4.977 ; 6.551 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2706 ; 3.148 ; 4.788 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2707 ; 3.148 ; 4.788 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 3922 ; 5.110 ; 6.986 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 5728 ; 7.670 ;51.053 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 5699 ; 7.658 ;51.062 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NCS TYPE: LOCAL REMARK 3 NUMBER OF DIFFERENT NCS PAIRS : 1 REMARK 3 GROUP CHAIN1 RANGE CHAIN2 RANGE COUNT RMS WEIGHT REMARK 3 1 A B 9715 0.11 0.05 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 8SKN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-APR-23. REMARK 100 THE DEPOSITION ID IS D_1000273659. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-JAN-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL19U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97843 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28133 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.410 REMARK 200 RESOLUTION RANGE LOW (A) : 47.660 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 6.800 REMARK 200 R MERGE (I) : 0.17500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.41 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.50 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 7.00 REMARK 200 R MERGE FOR SHELL (I) : 0.96600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 4H1V REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.14 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.05 M POTASSIUM CHLORIDE, 0.01 M REMARK 280 MAGNESIUM CHLORIDE, 15% W/V PEG6000, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 40.63500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -19 REMARK 465 GLY A -18 REMARK 465 SER A -17 REMARK 465 SER A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 SER A -9 REMARK 465 SER A -8 REMARK 465 GLY A -7 REMARK 465 LEU A -6 REMARK 465 VAL A -5 REMARK 465 PRO A -4 REMARK 465 ARG A -3 REMARK 465 LYS A 77 REMARK 465 THR A 78 REMARK 465 THR A 79 REMARK 465 GLY A 80 REMARK 465 GLU A 81 REMARK 465 GLU A 82 REMARK 465 ASN A 83 REMARK 465 GLY A 84 REMARK 465 VAL A 85 REMARK 465 GLU A 698 REMARK 465 PRO A 699 REMARK 465 VAL A 700 REMARK 465 ASP A 701 REMARK 465 ASP A 702 REMARK 465 LYS A 703 REMARK 465 HIS A 704 REMARK 465 GLY A 705 REMARK 465 THR A 706 REMARK 465 ASP A 707 REMARK 465 SER A 708 REMARK 465 GLU A 732 REMARK 465 THR A 733 REMARK 465 HIS A 734 REMARK 465 LEU A 735 REMARK 465 TRP A 736 REMARK 465 MET B -19 REMARK 465 GLY B -18 REMARK 465 SER B -17 REMARK 465 SER B -16 REMARK 465 HIS B -15 REMARK 465 HIS B -14 REMARK 465 HIS B -13 REMARK 465 HIS B -12 REMARK 465 HIS B -11 REMARK 465 HIS B -10 REMARK 465 SER B -9 REMARK 465 SER B -8 REMARK 465 GLY B -7 REMARK 465 LEU B -6 REMARK 465 VAL B -5 REMARK 465 PRO B -4 REMARK 465 ARG B -3 REMARK 465 THR B 55 REMARK 465 GLY B 56 REMARK 465 ILE B 57 REMARK 465 GLN B 72 REMARK 465 GLU B 73 REMARK 465 ASP B 74 REMARK 465 LYS B 75 REMARK 465 ARG B 76 REMARK 465 LYS B 77 REMARK 465 THR B 78 REMARK 465 THR B 79 REMARK 465 GLY B 80 REMARK 465 GLU B 81 REMARK 465 GLU B 82 REMARK 465 ASN B 83 REMARK 465 GLY B 84 REMARK 465 VAL B 85 REMARK 465 SER B 119 REMARK 465 GLY B 120 REMARK 465 ASN B 121 REMARK 465 ASN B 122 REMARK 465 SER B 695 REMARK 465 TYR B 696 REMARK 465 GLY B 697 REMARK 465 GLU B 698 REMARK 465 PRO B 699 REMARK 465 VAL B 700 REMARK 465 ASP B 701 REMARK 465 ASP B 702 REMARK 465 LYS B 703 REMARK 465 HIS B 704 REMARK 465 GLY B 705 REMARK 465 THR B 706 REMARK 465 ASP B 707 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 947 O HOH B 951 2.10 REMARK 500 O HOH A 904 O HOH A 972 2.14 REMARK 500 O HOH B 903 O HOH B 949 2.14 REMARK 500 OG SER B 275 O HOH B 901 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 50 -39.15 -161.90 REMARK 500 LYS A 97 -114.25 35.63 REMARK 500 ASN A 121 -149.55 -92.75 REMARK 500 ASN A 176 109.71 -53.95 REMARK 500 ASP A 190 97.98 -58.40 REMARK 500 VAL A 234 -57.34 -120.85 REMARK 500 HIS B 0 36.09 -141.26 REMARK 500 LEU B 50 -9.71 -163.39 REMARK 500 LYS B 97 -113.59 36.43 REMARK 500 SER B 136 137.55 -173.19 REMARK 500 ASN B 176 109.95 -52.33 REMARK 500 ASP B 190 107.32 -46.16 REMARK 500 ARG B 731 122.69 -37.79 REMARK 500 REMARK 500 REMARK: NULL DBREF 8SKN A 1 703 UNP D3DUW7 D3DUW7_HUMAN 54 382 DBREF 8SKN A 709 736 UNP D3DUW7 D3DUW7_HUMAN 725 752 DBREF 8SKN B 1 703 UNP D3DUW7 D3DUW7_HUMAN 54 382 DBREF 8SKN B 709 736 UNP D3DUW7 D3DUW7_HUMAN 725 752 SEQADV 8SKN MET A -19 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN GLY A -18 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN SER A -17 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN SER A -16 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN HIS A -15 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN HIS A -14 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN HIS A -13 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN HIS A -12 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN HIS A -11 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN HIS A -10 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN SER A -9 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN SER A -8 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN GLY A -7 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN LEU A -6 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN VAL A -5 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN PRO A -4 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN ARG A -3 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN GLY A -2 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN SER A -1 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN HIS A 0 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN HIS A 704 UNP D3DUW7 LINKER SEQADV 8SKN GLY A 705 UNP D3DUW7 LINKER SEQADV 8SKN THR A 706 UNP D3DUW7 LINKER SEQADV 8SKN ASP A 707 UNP D3DUW7 LINKER SEQADV 8SKN SER A 708 UNP D3DUW7 LINKER SEQADV 8SKN MET B -19 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN GLY B -18 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN SER B -17 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN SER B -16 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN HIS B -15 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN HIS B -14 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN HIS B -13 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN HIS B -12 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN HIS B -11 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN HIS B -10 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN SER B -9 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN SER B -8 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN GLY B -7 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN LEU B -6 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN VAL B -5 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN PRO B -4 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN ARG B -3 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN GLY B -2 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN SER B -1 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN HIS B 0 UNP D3DUW7 EXPRESSION TAG SEQADV 8SKN HIS B 704 UNP D3DUW7 LINKER SEQADV 8SKN GLY B 705 UNP D3DUW7 LINKER SEQADV 8SKN THR B 706 UNP D3DUW7 LINKER SEQADV 8SKN ASP B 707 UNP D3DUW7 LINKER SEQADV 8SKN SER B 708 UNP D3DUW7 LINKER SEQRES 1 A 382 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 382 LEU VAL PRO ARG GLY SER HIS MET GLU ALA LEU ILE PRO SEQRES 3 A 382 VAL ILE ASN LYS LEU GLN ASP VAL PHE ASN THR VAL GLY SEQRES 4 A 382 ALA ASP ILE ILE GLN LEU PRO GLN ILE VAL VAL VAL GLY SEQRES 5 A 382 THR GLN SER SER GLY LYS SER SER VAL LEU GLU SER LEU SEQRES 6 A 382 VAL GLY ARG ASP LEU LEU PRO ARG GLY THR GLY ILE VAL SEQRES 7 A 382 THR ARG ARG PRO LEU ILE LEU GLN LEU VAL HIS VAL SER SEQRES 8 A 382 GLN GLU ASP LYS ARG LYS THR THR GLY GLU GLU ASN GLY SEQRES 9 A 382 VAL GLU ALA GLU GLU TRP GLY LYS PHE LEU HIS THR LYS SEQRES 10 A 382 ASN LYS LEU TYR THR ASP PHE ASP GLU ILE ARG GLN GLU SEQRES 11 A 382 ILE GLU ASN GLU THR GLU ARG ILE SER GLY ASN ASN LYS SEQRES 12 A 382 GLY VAL SER PRO GLU PRO ILE HIS LEU LYS ILE PHE SER SEQRES 13 A 382 PRO ASN VAL VAL ASN LEU THR LEU VAL ASP LEU PRO GLY SEQRES 14 A 382 MET THR LYS VAL PRO VAL GLY ASP GLN PRO LYS ASP ILE SEQRES 15 A 382 GLU LEU GLN ILE ARG GLU LEU ILE LEU ARG PHE ILE SER SEQRES 16 A 382 ASN PRO ASN SER ILE ILE LEU ALA VAL THR ALA ALA ASN SEQRES 17 A 382 THR ASP MET ALA THR SER GLU ALA LEU LYS ILE SER ARG SEQRES 18 A 382 GLU VAL ASP PRO ASP GLY ARG ARG THR LEU ALA VAL ILE SEQRES 19 A 382 THR LYS LEU ASP LEU MET ASP ALA GLY THR ASP ALA MET SEQRES 20 A 382 ASP VAL LEU MET GLY ARG VAL ILE PRO VAL LYS LEU GLY SEQRES 21 A 382 ILE ILE GLY VAL VAL ASN ARG SER GLN LEU ASP ILE ASN SEQRES 22 A 382 ASN LYS LYS SER VAL THR ASP SER ILE ARG ASP GLU TYR SEQRES 23 A 382 ALA PHE LEU GLN LYS LYS TYR PRO SER LEU ALA ASN ARG SEQRES 24 A 382 ASN GLY THR LYS TYR LEU ALA ARG THR LEU ASN ARG LEU SEQRES 25 A 382 LEU MET HIS HIS ILE ARG ASP CYS LEU PRO GLU LEU LYS SEQRES 26 A 382 THR ARG ILE ASN VAL LEU ALA ALA GLN TYR GLN SER LEU SEQRES 27 A 382 LEU ASN SER TYR GLY GLU PRO VAL ASP ASP LYS HIS GLY SEQRES 28 A 382 THR ASP SER ARG ARG LYS GLU ALA ALA ASP MET LEU LYS SEQRES 29 A 382 ALA LEU GLN GLY ALA SER GLN ILE ILE ALA GLU ILE ARG SEQRES 30 A 382 GLU THR HIS LEU TRP SEQRES 1 B 382 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 382 LEU VAL PRO ARG GLY SER HIS MET GLU ALA LEU ILE PRO SEQRES 3 B 382 VAL ILE ASN LYS LEU GLN ASP VAL PHE ASN THR VAL GLY SEQRES 4 B 382 ALA ASP ILE ILE GLN LEU PRO GLN ILE VAL VAL VAL GLY SEQRES 5 B 382 THR GLN SER SER GLY LYS SER SER VAL LEU GLU SER LEU SEQRES 6 B 382 VAL GLY ARG ASP LEU LEU PRO ARG GLY THR GLY ILE VAL SEQRES 7 B 382 THR ARG ARG PRO LEU ILE LEU GLN LEU VAL HIS VAL SER SEQRES 8 B 382 GLN GLU ASP LYS ARG LYS THR THR GLY GLU GLU ASN GLY SEQRES 9 B 382 VAL GLU ALA GLU GLU TRP GLY LYS PHE LEU HIS THR LYS SEQRES 10 B 382 ASN LYS LEU TYR THR ASP PHE ASP GLU ILE ARG GLN GLU SEQRES 11 B 382 ILE GLU ASN GLU THR GLU ARG ILE SER GLY ASN ASN LYS SEQRES 12 B 382 GLY VAL SER PRO GLU PRO ILE HIS LEU LYS ILE PHE SER SEQRES 13 B 382 PRO ASN VAL VAL ASN LEU THR LEU VAL ASP LEU PRO GLY SEQRES 14 B 382 MET THR LYS VAL PRO VAL GLY ASP GLN PRO LYS ASP ILE SEQRES 15 B 382 GLU LEU GLN ILE ARG GLU LEU ILE LEU ARG PHE ILE SER SEQRES 16 B 382 ASN PRO ASN SER ILE ILE LEU ALA VAL THR ALA ALA ASN SEQRES 17 B 382 THR ASP MET ALA THR SER GLU ALA LEU LYS ILE SER ARG SEQRES 18 B 382 GLU VAL ASP PRO ASP GLY ARG ARG THR LEU ALA VAL ILE SEQRES 19 B 382 THR LYS LEU ASP LEU MET ASP ALA GLY THR ASP ALA MET SEQRES 20 B 382 ASP VAL LEU MET GLY ARG VAL ILE PRO VAL LYS LEU GLY SEQRES 21 B 382 ILE ILE GLY VAL VAL ASN ARG SER GLN LEU ASP ILE ASN SEQRES 22 B 382 ASN LYS LYS SER VAL THR ASP SER ILE ARG ASP GLU TYR SEQRES 23 B 382 ALA PHE LEU GLN LYS LYS TYR PRO SER LEU ALA ASN ARG SEQRES 24 B 382 ASN GLY THR LYS TYR LEU ALA ARG THR LEU ASN ARG LEU SEQRES 25 B 382 LEU MET HIS HIS ILE ARG ASP CYS LEU PRO GLU LEU LYS SEQRES 26 B 382 THR ARG ILE ASN VAL LEU ALA ALA GLN TYR GLN SER LEU SEQRES 27 B 382 LEU ASN SER TYR GLY GLU PRO VAL ASP ASP LYS HIS GLY SEQRES 28 B 382 THR ASP SER ARG ARG LYS GLU ALA ALA ASP MET LEU LYS SEQRES 29 B 382 ALA LEU GLN GLY ALA SER GLN ILE ILE ALA GLU ILE ARG SEQRES 30 B 382 GLU THR HIS LEU TRP HET 6I9 A 801 27 HET EDO A 802 4 HET EDO A 803 4 HET EDO A 804 4 HET EDO A 805 4 HET EDO A 806 4 HET EDO A 807 4 HET EDO A 808 4 HET EDO B 801 4 HET EDO B 802 4 HET EDO B 803 4 HET EDO B 804 4 HETNAM 6I9 N-[4-(AZETIDIN-1-YL)-2-(4-METHYLPHENYL)QUINOLIN-6-YL]- HETNAM 2 6I9 2-METHYLPROPANAMIDE HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 3 6I9 C23 H25 N3 O FORMUL 4 EDO 11(C2 H6 O2) FORMUL 15 HOH *158(H2 O) HELIX 1 AA1 HIS A 0 GLU A 2 5 3 HELIX 2 AA2 ALA A 3 PHE A 15 1 13 HELIX 3 AA3 ASN A 16 GLN A 24 1 9 HELIX 4 AA4 THR A 33 SER A 36 5 4 HELIX 5 AA5 GLY A 37 GLY A 47 1 11 HELIX 6 AA6 ASP A 103 GLU A 116 1 14 HELIX 7 AA7 LYS A 160 SER A 175 1 16 HELIX 8 AA8 ASP A 190 THR A 193 5 4 HELIX 9 AA9 SER A 194 GLU A 202 1 9 HELIX 10 AB1 LYS A 216 MET A 220 5 5 HELIX 11 AB2 ALA A 226 MET A 231 1 6 HELIX 12 AB3 SER A 248 ASN A 254 1 7 HELIX 13 AB4 SER A 257 TYR A 273 1 17 HELIX 14 AB5 LEU A 276 ASN A 280 5 5 HELIX 15 AB6 GLY A 281 SER A 321 1 41 HELIX 16 AB7 ARG A 710 GLU A 729 1 20 HELIX 17 AB8 HIS B 0 GLU B 2 5 3 HELIX 18 AB9 ALA B 3 PHE B 15 1 13 HELIX 19 AC1 ASN B 16 GLN B 24 1 9 HELIX 20 AC2 GLN B 34 SER B 36 5 3 HELIX 21 AC3 GLY B 37 GLY B 47 1 11 HELIX 22 AC4 ASP B 103 THR B 115 1 13 HELIX 23 AC5 LYS B 160 SER B 175 1 16 HELIX 24 AC6 ASP B 190 THR B 193 5 4 HELIX 25 AC7 SER B 194 GLU B 202 1 9 HELIX 26 AC8 LYS B 216 MET B 220 5 5 HELIX 27 AC9 ALA B 226 MET B 231 1 6 HELIX 28 AD1 SER B 248 ASN B 254 1 7 HELIX 29 AD2 SER B 257 TYR B 273 1 17 HELIX 30 AD3 LEU B 276 ASN B 280 5 5 HELIX 31 AD4 GLY B 281 ASN B 320 1 40 HELIX 32 AD5 ARG B 709 GLU B 729 1 21 SHEET 1 AA1 8 TRP A 90 PHE A 93 0 SHEET 2 AA1 8 ILE A 130 SER A 136 -1 O PHE A 135 N TRP A 90 SHEET 3 AA1 8 LEU A 63 HIS A 69 1 N GLN A 66 O ILE A 134 SHEET 4 AA1 8 LEU A 142 ASP A 146 -1 O LEU A 142 N LEU A 67 SHEET 5 AA1 8 GLN A 27 VAL A 31 1 N ILE A 28 O VAL A 145 SHEET 6 AA1 8 SER A 179 ALA A 186 1 O LEU A 182 N VAL A 29 SHEET 7 AA1 8 THR A 210 THR A 215 1 O VAL A 213 N ALA A 183 SHEET 8 AA1 8 ILE A 241 GLY A 243 1 O ILE A 242 N ALA A 212 SHEET 1 AA2 8 TRP B 90 PHE B 93 0 SHEET 2 AA2 8 ILE B 130 SER B 136 -1 O PHE B 135 N TRP B 90 SHEET 3 AA2 8 LEU B 63 HIS B 69 1 N ILE B 64 O ILE B 130 SHEET 4 AA2 8 LEU B 142 ASP B 146 -1 O LEU B 142 N LEU B 67 SHEET 5 AA2 8 GLN B 27 GLY B 32 1 N ILE B 28 O VAL B 145 SHEET 6 AA2 8 SER B 179 ALA B 186 1 O LEU B 182 N VAL B 29 SHEET 7 AA2 8 THR B 210 THR B 215 1 O VAL B 213 N ALA B 183 SHEET 8 AA2 8 ILE B 241 GLY B 243 1 O ILE B 242 N ALA B 212 CRYST1 47.580 81.270 97.080 90.00 101.19 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021017 0.000000 0.004158 0.00000 SCALE2 0.000000 0.012305 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010500 0.00000